International Symposium 6
Standard Treatment for MIS for Endometrial Cancer

2021年9月12日(日) 16:30 〜 18:00 第3会場 (5F 502)

Chairpersons：Daisuke Aoki（Department of Obstetrics and Gynecology, Keio University School of Medicine, Japan）, Ting-Chang Chang（Chang Gung University Medical College and Chang Gung Memorial Hospital, Taiwan）

[IS6-1] Standard treatment for MIS for endometrial cancer in Japan

^○Yoshito Terai (Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Japan)

[IS6-2] Current evidence for a potential usefulness of sentinel lymph node biopsy in the management of endometrial cancer

^○Fumio Kataoka (Department of Obstetrics and Gynecology, International University of Health and Welfare, School of Medicine, Japan)

[IS6-3] Nationwide Comparison of Surgical and Oncologic Outcomes in Endometrial Cancer Patients Undergoing Robotic, Laparoscopic, and Open Surgery

^○Young Tae Kim (Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea)

[IS6-4] What have we learned from gynecological endoscopic surgery for endometrial cancer?

^○Tsukasa Baba, Takayuki Nagasawa, Yoshitaka Kaido, Shunsuke Tatsuki, Eriko Takatori, Masahiro Kagabu, Tadahiro Shoji (Department of Obstetrics and Gynecology, Iwate Medical University, Iwate, Japan)

[IS6-5] Can ovarian preservation be considered? Molecular based selection for MIS in endometrial cancer

^○Ting-Chang Chang (Department of Obstetrics and Gynecology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan)